Le Lézard
Classified in: Health
Subjects: PSF, CFG, MAT

Public Advisory - Health Canada warns about multiple unauthorized sexual enhancement products that may pose serious health risks


OTTAWA, ON, April 8, 2024 /CNW/ - Health Canada is advising that the following product(s) may pose serious health risks. For more information, including product photos and what you should do, visit these online safety alerts:

Health Canada maintains lists of unauthorized health products that may pose serious health risks so that the public can easily identify those they may have purchased and take appropriate action. You are encouraged to check back regularly for updates.

Product

Hazard Identified

Company

Action Taken

Unauthorized health products for sexual enhancement

Black Bull Extreme

Product tested by Health
Canada and found to contain
sildenafil and tadalafil

Neighbourhood Convenience

894 Mount Pleasant Rd,

Toronto, ON

Seized from retail
location

Black Mamba Premium
Triple Maximum

Product tested by Health
Canada and found to contain
sildenafil and tadalafil

Neighbourhood Convenience

894 Mount Pleasant Rd,

Toronto, ON

Seized from retail
location

Black Panther #1

Labelled to contain yohimbe

New DoingWell Convenience

171 Ravel Rd,

Toronto, ON

Seized from retail
location

Rhino 7 Platinum 5000

Product with similar packaging
(previously seized) was tested
and found to contain sildenafil
and yohimbine

New DoingWell Convenience

171 Ravel Rd,

Toronto, ON

Seized from retail
location

White Panther

Labelled to contain yohimbe

New DoingWell Convenience

171 Ravel Rd,

Toronto, ON

Seized from retail
location

Wonderful Honey

Product tested by Health
Canada and found to contain
sildenafil

Chez Olivia Inc.

5130 Rue Beaubien Est

Montréal, QC

Seized from retail
location

Wonderfull Honey

Product tested by Health
Canada and found to contain
sildenafil

Chez Olivia Inc.

5130 Rue Beaubien Est

Montréal, QC

Seized from retail
location

Stay connected with Health Canada and receive the latest advisories and product recalls.

Également disponible en français

SOURCE Health Canada (HC)


These press releases may also interest you

at 04:15
Fastest Labs Announces Expansion into Coastal North Carolina
Fastest Labs, a leading national drug, alcohol, and DNA testing company, is expanding its presence in North Carolina with a new franchise location in Wilmington, NC. The move marks a significant stride in the company's efforts to provide fast,...

at 04:15
New multi-stakeholder industry initiative launched in the UK to take collaborative action on recycling of primary pharmaceutical packaging
The Circularity in Primary Pharmaceutical Packaging Accelerator (CiPPPA) initiative launched this week to tackle the challenges of recycling medicinal devices and pharmaceutical packaging. The pharmaceutical industry faces recycling difficulties due...

at 04:06
Resource-Appropriate Cancer Care, Including Coexisting Health Issues of HIV and Cancer, to be Addressed During Meeting in Nairobi
Local and global experts are meeting in Nairobi, Kenya to update clinical practice guidelines as part of ongoing work with Allied Against Cancer?a collaboration between the National Comprehensive Cancer Network® (NCCN®), African...

at 04:00
Ellipses' next generation selective RET inhibitor EP0031/A400 cleared to start Phase 2
Ellipses Pharma Limited ("Ellipses"), a global drug development company focused on accelerating the development of cancer treatments through an innovative drug development model, announced today the U.S. Food and Drug Administration (FDA) has...

at 02:30
Pop-R&B Artist & International Award-Winning Classical Pianist Janet Noh Releases Critically Acclaimed 'Oh Child' Record and Film Production. 100% of Proceeds Are Being Donated to the Korean American Family Service Center, Supporting Survivors of Domestic Abuse.
On April 30th, 2024, in celebration of Mental Health Awareness Month and AAPI Heritage Month,  international award-winning classical pianist and pop-R&B singer Janet Noh released her newest record 'Oh Child' as well as its accompanying cinematic...

at 02:05
Epsilogen Appoints Ashley Nagle as Chief Business Officer and Peter Finan as Non-Executive Chairman as Part of Broader Company Expansion
Epsilogen, a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, today announces the appointments of Ashley Nagle as Chief Business Officer (CBO) and Peter Finan, currently a Non-Executive Director, as Non-Executive...

More news about Health...


News published on and distributed by: